Biostatistics - read more

All services required in the lifecycle of clinical development projects, beginning with biostatistical consulting during development of the project concept up to contributions for submissions or HTA dossiers and post approval studies


AMS  Services include:

  • Biostatistical consulting and writing for clinical trials and observational research studies
  • Sample size calculations
  • Randomization (with optional integration of the randomization list into the eCRF)
  • Biostatistical review of key documents
  • Support of / Participation in Monitoring Committees
  • Comprehensive and detailed statistical analysis plans (SAP)
  • Review and contributions to study reports/posters/manuscripts
  • SAS Programming for the analysis, review listings, periodic safety reports or trial results reporting to EudraCT database and implementation of CDISC SDTM / ADaM standards.
  • Health Economics,  Patient surveys, Interim analysis, Adaptive designs, Burden of Disease studies, cost-effectiveness analyses, quality of life evaluation
  • Continuous training on all applicable guidelines is part of our Quality Management System.

All services are performed on validated systems (SAS, NQuery, Pinnacle 21 Community Validator) following all applicable guidelines (e.g. GCP, ICH E3/E9, 21 CFR part 11).
The aim of clinical research is to gather data and to derive information from it. Use AMS  experience and training to your benefit to help you select the optimal study design and appropriate endpoints for the objectives of the project, and by providing time- and cost-efficient conduct of all services with high quality deliverables.

Within a project, the Biostatisticians provide ongoing support/consulting and status reports to the Sponsor and project team and cooperate closely with Sponsor scientists, project managers, data managers, medical monitors to provide the optimal solution for your needs.


Get in contact:


• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS-ePRO (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence


  • EUnetHTA Open Call for Early Dialogue Requests

    EUnetHTA Open Call for Early Dialogue...

    Artikel vom 09 Juli 2020 News
    EUnetHTA’s Joint Action 3 has been prolonged to May 31, 2021. After a temporary suspension of Early Dialogues (ED) due to the current pandemic situation, ED...
  • EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL)

    EUnetHTA publishes the second...

    Artikel vom 01 August 2019 News
    It’s time to get involved: EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL) EUnetHTA’s Joint Action 3 will definitely end in...
  • EMA-EUnetHTA Parallel Consultation

    EMA-EUnetHTA Parallel Consultation

    Artikel vom 01 August 2017 News
    Profit from the simultaneous feedback of regulatory and HTA bodies in order to generate your data set in the most efficient way! What is new? EMA and EUnetHTA have...
  • AbbVie TRIUMPH AWARD 2015

    AbbVie TRIUMPH AWARD 2015

    Artikel vom 24 Juni 2016 News
    Um Kooperationen auszuzeichnen und Partner entsprechend zu honorieren, verleiht AbbVie Global jährlich den Preis 'Supplier of the Year'. Kriterien, um für den...
  • AMS electronic Patient Reported Outcomes (AMS-ePRO®)

    AMS electronic Patient Reported...

    Artikel vom 01 Juni 2016 News
    AMS electronic Patient Reported Outcomes (AMS-ePRO®) AMS-ePRO® supports Clinical Research You can now capture your patients data Anytime Anywhere with...